244 related articles for article (PubMed ID: 10878502)
1. Immunopathological factors for vertical transmission of HIV-1.
Edgeworth RL; Ugen KE
Pathobiology; 2000; 68(2):53-67. PubMed ID: 10878502
[TBL] [Abstract][Full Text] [Related]
2. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Jackson JB; Musoke P; Fleming T; Guay LA; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Owor M; Ducar C; Deseyve M; Mwatha A; Emel L; Duefield C; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Gigliotti M; Bray D; Mmiro F
Lancet; 2003 Sep; 362(9387):859-68. PubMed ID: 13678973
[TBL] [Abstract][Full Text] [Related]
3. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
[TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
5. Unequal care sustains vertical transmission rate.
Kasper T
GMHC Treat Issues; 1999 Feb; 13(2):11-2. PubMed ID: 11366115
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
7. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
8. Zidovudine monotherapy and the prevention of mother-to-child HIV-1 transmission.
Hudson CP
Lancet Infect Dis; 2005 Feb; 5(2):68. PubMed ID: 15680770
[No Abstract] [Full Text] [Related]
9. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
[TBL] [Abstract][Full Text] [Related]
10. HIVNET 012 and Petra.
Jackson B; Mmiro F;
Lancet; 2004 Jan; 363(9404):245; author reply 245-6. PubMed ID: 14738808
[No Abstract] [Full Text] [Related]
11. Single-dose Nevirapine during pregnancy.
Sax PE
AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708
[TBL] [Abstract][Full Text] [Related]
12. Further views by the Erice working group on mother-to-child transmission of HIV type 1.
Dovie Akue JP; Babaki P; Barré-Sinoussi F; Charpak N; de Thé G; Ferreira Rea M; Huraux C; Ndiaye B; Pratomo H; Samuel NM; Wilfert C; Zetterström R
Acta Paediatr; 2001 Jan; 90(1):102-3. PubMed ID: 11227325
[No Abstract] [Full Text] [Related]
13. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
Herzmann C; Karcher H
N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729
[No Abstract] [Full Text] [Related]
14. Feeding risk cut for HIV-infected women.
Das P
Lancet; 2003 Jul; 362(9380):300. PubMed ID: 12892984
[No Abstract] [Full Text] [Related]
15. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
16. HIVNET nevirapine trials.
Lurie P; Wolfe SM
Lancet; 1999 Nov; 354(9192):1816-7. PubMed ID: 10577660
[No Abstract] [Full Text] [Related]
17. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E
Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
19. AZT blues.
Lala SG; Cooper PA; Gray GE; Jivkov BI; Schorn MC
S Afr Med J; 2000 Jul; 90(7):656. PubMed ID: 10985115
[No Abstract] [Full Text] [Related]
20. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
Nightingale S; Dabis F
J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
